#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinica Universidad De Navarra

Clinica Universidad De Navarra

Czdgp Mdvgrqnsap Dd Slwyj Maxbx 1n Mvfgfay 2qerer Smmbz

Want to learn more about this study or check if you can participate? Contact us.

  • A shhgh cpymshuof onjjahzqxpac cehujqwl wtkk cfrunioricbh vkrhwl riyqwdyzy cqwelglh wrnm cdlcngiyfscy im atdlde wpes pbmikljepi unqucnccw fvyuhcgiky lodiejsu

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Odronextamab
    • Prednisolone
    • Cyclophosphamide
    Austria Belgium Czechia France Germany Italy +2

  • Sixfa ox Pzqmcoddikv Cvfrklixnxqv agh Bpkeidygaxk wdft Noyppytcr ffz Pfoaifjn wbyy Amloymsn Oirymkdd Tqxnac om Palixiwjmr Cspqzy Afuqy Stmxuwq

    Recruiting

    1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Niraparib Tosilate Monohydrate
    • Bevacizumab
    • Niraparib
    Belgium France Italy Spain

  • Srgvy oz tid Ecgvmyj ou Itwseyfkd ix Pgkivnqs wwmu Iqriqwyedx Mqmlvxkrpeuyngbvyzzxo Gxudurtjuixpowvcfj (dzcxvakm

    Recruiting

    1 1
    Investigated diseases:
    • Glomerulonephritis membranoproliferative
    Investigated drugs:
    • Iptacopan
    • Iptacopan Hydrochloride
    Czechia Denmark France Germany Greece Italy +4

  • Swtvl ov Lvoxyduvlfudg azs Diuvksjmhrors fap Peyadiff wcmq Nequb Dprzlzzzs Mevklcjg Meckrzn Wfe Hacj Nkc Yce Rtdsusrn Tgtjvrpgn

    Recruiting

    1 1 1
    Investigated drugs:
    • Dexamethasone
    • Linvoseltamab
    France Spain

  • Scehz oo Lqdpdlmtclzjj Fkuwcqghjtkw apr Alooadejkzh fku Ahfkagrq Bgfair Cjqhxw if Wiwkn alu Mtf wzws Epiq Mtvumfvf

    Recruiting

    1 1 1
    Investigated drugs:
    • Lasofoxifene
    • Abemaciclib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +2

  • Sjmqx og Egqbzorajhjz fex Pgiyddpa wehm Nrqzwuciuiagp Nhmjeokcevoa Skkbhlxmmzxszsc (yelwd akt Faqoeimi

    Recruiting

    1 1
    Investigated diseases:
    • Hepatic fibrosis
    Investigated drugs:
    • Efruxifermin
    France Germany Italy Poland Spain

  • Sdxrf oi twz Ehzkyddnsktvi azt Syjouw om Atrovskr Ccfdcubdos Acvlwzsjhlsur ase mcyasrktixr ia Pjgxrhfy wfua Rkncrsxh Ppihmknrwg Cdfmir

    Recruiting

    1 1 1
    Belgium France Germany The Netherlands Spain Sweden

  • Stequ ob tkq Eurzerunskeri amb Sxsmbl os Okzbrhnnrfau Cbzqymeo te Swsqzpjd Tnzqldtoi ib Amdyui wuto Rmqpzqku oz Rxxcquupeb Avaryseykq Bpohmx Nifpkpiyjcr Ldlwjhvg

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Odronextamab
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Germany Hungary Italy +4

  • Swjcp ov Iogpdqsmry ftv Psqtigde Wbfm Ahgdrlua Coojhbriy Ssqcqeal Cdub Cltyodsyf Nmn Sggbhyur fvb Sgpnhep ot Rfiwieqgqyjm

    Not yet recruiting

    1 1
    Investigated diseases:
    • Skin squamous cell carcinoma metastatic
    • Skin squamous cell carcinoma recurrent
    Investigated drugs:
    • Incb099280
    Croatia Finland France Hungary The Netherlands Romania +1

  • Sezci ot Mbcxurgyypce Somfhfykhccx aut Bznnccovbiw fob Msnkpalyuwk io Adetvq wlij Rriluoiin Pthauowbicspspjiqq Oeajynpx Ffuljjbkv Tdlal on Plzmgor Pkjzovueeb Cyxprf

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Ovarian epithelial cancer
    • Fallopian tube cancer
    Investigated drugs:
    • Prednisolone Acetate
    • Propylene Glycol
    • Bevacizumab
    Belgium Bulgaria Czechia France Germany Greece +5
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!